(Q34345668)

1 August 2017

Measurement of steroid hormone receptors in breast cancer patients on tamoxifen (English)

1 reference

1 August 2017

0 references

1 reference

1 reference

Encarnación CA

1

1 reference

1 August 2017

Ciocca DR

2

1 reference

1 August 2017

McGuire WL

3

1 reference

1 August 2017

Clark GM

4

1 reference

1 August 2017

Fuqua SA

5

1 reference

1 August 2017

Osborne CK

6

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 January 1993

1 reference

Breast Cancer Research and Treatment

1 August 2017

1 reference

1 August 2017

26

1 reference

1 August 2017

237-246

1 reference

1 August 2017

3

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00665801

1 August 2017

0 references

cites work

Effects of endocrine therapy on steroid-receptor content of breast cancer

1 reference

12 December 2020

Endocrine therapy for advanced carcinoma of the breast: relationship between the effect of tamoxifen upon concentrations of progesterone receptor and subsequent response to treatment

1 reference

12 December 2020

Variant human breast tumor estrogen receptor with constitutive transcriptional activity

1 reference

12 December 2020

Beneficial effect of adjuvant tamoxifen therapy in primary breast cancer patients with high oestrogen receptor values

1 reference

12 December 2020

The changing role of hormonal therapy in advanced breast cancer

1 reference

12 December 2020

Identification of estrogenic tamoxifen metabolite(s) in tamoxifen-resistant human breast tumors

1 reference

12 December 2020

Estrogen control of progesterone receptor in human breast cancer: role of estradiol and antiestrogen

1 reference

12 December 2020

Estrogen receptors and breast cancer response to adrenalectomy

1 reference

12 December 2020

Up-regulation of estrogen receptors by nonsteroidal antiestrogens in human breast cancer.

1 reference

12 December 2020

Multiple progesterone receptor assays in human breast cancer.

1 reference

12 December 2020

Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Early Breast Cancer Trialists' Collaborative Group

1 reference

12 December 2020

Antiestrogen resistance: mechanisms by which breast cancer cells undermine the effectiveness of endocrine therapy.

1 reference

12 December 2020

Induction of progesterone receptor with tamoxifen in human breast cancer with special reference to its behavior over time

1 reference

12 December 2020

Prognostic significance of progesterone receptor levels in estrogen receptor-positive patients with metastatic breast cancer treated with tamoxifen: results of a prospective Southwest Oncology Group study

1 reference

12 December 2020

Tamoxifen and the isomers of 4-hydroxytamoxifen in tamoxifen-resistant tumors from breast cancer patients

1 reference

12 December 2020

DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens

1 reference

12 December 2020

Evaluation of estrogen receptor assays in human breast cancer tissue

1 reference

12 December 2020

Purification of T47D human progesterone receptor and immunochemical characterization with monoclonal antibodies

1 reference

12 December 2020

Increase of progesterone receptor by tamoxifen as a hormonal challenge test in breast cancer

1 reference

12 December 2020

Hormonal strategies for breast cancer: a new focus on the estrogen receptor as a therapeutic target

1 reference

12 December 2020

Effects of tamoxifen on estrogen and progesterone receptors in human breast cancer

1 reference

12 December 2020

Effect of alpha-interferon, 17 beta-estradiol, and tamoxifen on estrogen receptor concentration and cell cycle kinetics of MCF 7 cells

1 reference

12 December 2020

Stability of oestrogen receptor status in sequential biopsies from patients with breast cancer

1 reference

12 December 2020

Changes of steroid hormone receptor content by chemotherapy and/or endocrine therapy in advanced breast cancer

1 reference

12 December 2020

Tamoxifen. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic use.

1 reference

12 December 2020

Acquired tamoxifen resistance: correlation with reduced breast tumor levels of tamoxifen and isomerization of trans-4-hydroxytamoxifen.

1 reference

12 December 2020

Immunochemical studies of estrogen receptors

1 reference

12 December 2020

Measurement of progesterone receptor in human breast cancer biopsies

1 reference

12 December 2020

Sensitivity and detection efficiency of the peroxidase antiperoxidase (PAP), avidin-biotin peroxidase complex (ABC), and peroxidase-labeled avidin-biotin (LAB) methods.

1 reference

12 December 2020

Multiple estrogen receptor assays in human breast cancer.

1 reference

12 December 2020

Immunohistochemical techniques using monoclonal antibodies

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00665801

1 reference

Dimensions Publication ID

1 August 2017

0 references

1 reference